(EMAILWIRE.COM, June 05, 2018 ) The Global Atrial Fibrillation Surgery Market was worth USD 1.02 billion in 2016, and is expected to grow at a CAGR of 14%, to reach USD 1.98 billion by 2021. Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, and shortness of breath and heart palpitations.

Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.

Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.

The Atrial Fibrillation Surgery Market is categorized based on the surgical procedure, product and region. Based on surgical procedure, the market is categorized into Catheter Ablation procedure and Surgical Ablation or Maze procedure. Based on product, the market is categorized into Catheter Ablation and Surgical Ablation. Catheter ablation surgical devices are expected to be the largest segment and are also expected be the fastest growing segment due to its high acceptance in surgical procedures.

Based on geography, the market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America leads the Atrial Fibrillation Surgery market due to availability of highly advanced healthcare infrastructure and adoption of highly advanced technologies. Asia Pacific is expected to be the fastest growing segment due to the large number of geriatric population who has a high risk of heart diseases.

View sample: https://www.marketdataforecast.com/market-reports/atrial-fibrillation-surgery-market-4066/request-sample

Some of the major players in this region are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.

About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results